1. Anon (1991) Guidelines for general pharmacology studies. Ministry of Health and Welfare, Tokyo
2. Anon (1995) Guidelines for general pharmacology studies—Japanese guidelines for non-clinical studies of drugs manual. Nippo Yakuji, Ltd, pp 71–80
3. Anon (1997a) Points to consider: the assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products, pp CPMP/986-96
4. Anon (1997b) ICH guidance for industry – M3(R2) nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals.
http://www.fda.gov/
5. Anon (1997c) ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals, pp EMA/CPMP/ICH/286-1995